IL6 and neoplasm: Conversely, in the presence of high levels of IL-6 and PGE2, intratumoral cDC2s can also be driven toward a pro-tumor phenotype characterized by CD14 expression, upregulation of markers usually associated with tumor-associated macrophages (TAMs), and impaired antigen processing and presentation (76–78).